Cost-effectiveness of olaparib vs routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore

Please use this identifier to cite or link to this item: https://doi.org/10.1093/annonc/mdz426.007

DC Field	Value
dc.title	Cost-effectiveness of olaparib vs routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
dc.contributor.author	Tan, DS
dc.contributor.author	Chan, JJ
dc.contributor.author	Loke, JK
dc.contributor.author	Hettle, R
dc.contributor.author	Ghosh, W
dc.contributor.author	Viswambaram, A
dc.contributor.author	Yu, CC
dc.date.accessioned	2021-01-05T23:58:57Z
dc.date.available	2021-01-05T23:58:57Z
dc.date.issued	2019-11
dc.identifier.citation	Tan, DS, Chan, JJ, Loke, JK, Hettle, R, Ghosh, W, Viswambaram, A, Yu, CC (2019-11). Cost-effectiveness of olaparib vs routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore. Annals of Oncology 30 : ix79-ix80. ScholarBank@NUS Repository. https://doi.org/10.1093/annonc/mdz426.007
dc.identifier.issn	09237534
dc.identifier.uri	https://scholarbank.nus.edu.sg/handle/10635/185321
dc.publisher	Elsevier BV
dc.source	Elements
dc.type	Article
dc.date.updated	2021-01-05T12:54:46Z
dc.contributor.department	MEDICINE
dc.description.doi	10.1093/annonc/mdz426.007
dc.description.sourcetitle	Annals of Oncology
dc.description.volume	30
dc.description.page	ix79-ix80
dc.published.state	Published
Appears in Collections:	Staff Publications Elements

File	Description	Size	Format	Access Settings	Version
cost effectiveness olaparib.pdf		66.58 kB	Adobe PDF	OPEN	Published	View/Download

Check